Abstract
Immunotherapy is currently one of the most promising treatment options for malignant melanoma. To uncover new immunological targets for future treatment approaches, single-cell transcriptomic and epigenomic analyses were performed on human primary melanoma and melanocytic nevus samples. The detailed methods of this study are described in the Supplementary Material.
Users
Please
log in to take part in the discussion (add own reviews or comments).